Walleye Capital’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Buy |
+214,817
| New | +$782K | ﹤0.01% | 920 |
|
|
2021
Q4 | – | Sell |
-276,260
| Closed | -$796 | – | 2012 |
|
|
2021
Q3 | $796 | Sell |
276,260
-46,193
| -14% | -$133 | 0.02% | 548 |
|
|
2021
Q2 | $1.22K | Buy |
322,453
+261,440
| +428% | +$991 | 0.04% | 353 |
|
|
2021
Q1 | $207 | Buy |
61,013
+1,071
| +2% | +$4 | 0.01% | 904 |
|
|
2020
Q4 | $168 | Sell |
59,942
-53,188
| -47% | -$149 | 0.01% | 737 |
|
|
2020
Q3 | $284K | Buy |
+113,130
| New | +$284K | 0.03% | 505 |
|
|
2019
Q4 | – | Sell |
-7,419
| Closed | -$29K | – | 640 |
|
|
2019
Q3 | $29K | Buy |
7,419
+5,695
| +330% | +$22.3K | ﹤0.01% | 392 |
|
|
2019
Q2 | $8K | Buy |
+1,724
| New | +$8K | ﹤0.01% | 439 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 372 |
|